Acquisition Growth MOS Plastics is part of a recent strategic expansion through Currier Plastics acquisitions, signaling heightened demand for contract manufacturing in healthcare. This creates cross-sell opportunities to existing Currier customers and potential for bundled services across design, molding, assembly, and sterilization.

Healthcare Focus With emphasis on medical devices, diagnostics, drug delivery, and life sciences, MOS targets high-growth, regulated markets. This aligns with selling opportunities in regulated cleanroom manufacturing, quality compliance, and rapid ramp-up capabilities for next-generation minimally invasive and biologic delivery platforms.

Technical Advantage Advanced molding capabilities (micro, two-shot, over-molding, blow) and cleanroom operations (ISO 8/ISO 7) position MOS to win complex, high-precision components. Sales angles include design for manufacturability, regulatory support, and post-molding sterilization management for critical devices.

Global Growth Revenue in the positioning range of tens of millions and integration into a broader Currier platform suggests capacity for scaled programs. Opportunities exist to onboard larger OEM projects, multi-site programs, and end-to-end manufacturing with accelerated speed-to-market.

Strategic Leadership Recent board appointments and CEO leadership under Sheridan Capital indicate a focus on governance and growth strategies. Use this to frame partnerships around reliable supply, strategic investments, and long-term contracts with clear milestones and performance metrics.